Long-term effects of dupilumab on chronic rhinosinusitis with nasal polyps: A step towards clinical remission

Background and objectives: Clinical remission, defined as the absence of disease activity and symptoms, is an emerging goal in the management of chronic rhinosinusitis with nasal polyps (CRSwNP). This study aimed to evaluate the long-term effects of dupilumab on patients with CRSwNP, with or without...

Full description

Bibliographic Details

Published in:	World Allergy Organization Journal
Main Authors:	Mona Al-Ahmad, MD, FRCPC, Asmaa Ali, MD, PhD, Wafaa Talat, MD, PhD, Haitham A. Dawood, MD, PhD, Osama Imam, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Subjects:	Chronic rhinosinusitis Nasal polyps Comorbid asthma Dupilumab Clinical remission Lund-mackay score
Online Access:	http://www.sciencedirect.com/science/article/pii/S193945512400156X